Skip to content

three-dimensional power Doppler ultrasound and endometrial receptivity of IVF-ET

three-dimensional power Doppler ultrasound and endometrial receptivity of IVF-ET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17011762
Enrollment
Unknown
Registered
2017-06-26
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Gold Standard:4-5 weeks after the embryo transfer, the ultrasound examination showed that the pregnant sac in the uterus was considered as clinical pregnancy, and divided into the pregnancy group and
ultrasonography

Sponsors

Jiangsu Province Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. clinical diagnosis of infertility patients (edited by Le Jie "obstetrics and Gynecology" normal sexual life without contraception for 1 years before pregnancy; a woman who has never pregnancy for primary infertility, pregnancy and then had no contraception for 1 years without pregnancy for secondary infertility) in the treatment of Reproductive Medicine Department of our hospital, to IVF-ET; 2. Aged 18~45 year women experienced sexual life; 3. informed consent voluntary test. The process of obtaining informed consent shall comply with the provisions of GCP.

Exclusion criteria

Exclusion criteria: 1. endometrial adhesion, polyps, submucosal fibroids or other space occupying diseases, such as uterine malformation; 2. acute pelvic inflammatory disease; 3. have serious primary heart, liver, lung, kidney, blood or the serious disease that affects its existence; 4. epileptic patients, or because of mental or behavioral disorders, do not give full informed consent; 5. suspected or indeed a history of alcohol or substance abuse; 6. according to the researcher's judgment, the possibility of reducing the possibility of entering a group or complicating other complications, such as frequent changes in the work environment, easily lead to lost access; 7. allergies, such as allergies to two or more drugs or foods; 8. patients who are participating in other clinical trials of drugs; 9. patients with infectious diseases.

Design outcomes

Primary

MeasureTime frame
Endometrial volume;Vascularization index;blood flow index;vascular blood flow index;Endometrial thickness;endometrial type;peak systolic velocity of uterine artery flow ;diastolic flow velocity of uterine artery flow;pulsatility index of uterine artery flow;resistance index of uterine artery flow;

Countries

China

Contacts

Public ContactYunfei Ma

Jiangsu Province Traditional Chinese Medicine Hospital

439925904@qq.com+86 13851420231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026